Safety and efficacy of eribulin mesylate (EM) in patients with advanced breast cancer: The Royal Marsden experience.
Eirini Thanopoulou
Honoraria - Eisai
Claudia Omarini
No relevant relationships to disclose
Belinda Yeo
No relevant relationships to disclose
Mark Allen
No relevant relationships to disclose
Marina Parton
No relevant relationships to disclose
Nicholas C. Turner
No relevant relationships to disclose
Mary E.R. O'Brien
No relevant relationships to disclose
Stephen R. D. Johnston
No relevant relationships to disclose
Ian E. Smith
No relevant relationships to disclose